Results showed that FGFR2 gene deletion led to significantly fewer precancerous lesions and delayed PDAC tumor formation ...
15h
News-Medical.Net on MSNMouse and organoid models reveal FGFR2's role in pancreatic cancer aggression and interceptionPancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it's diagnosed, it's often ...
CSHL Professor David Tuveson and Research Investigator Claudia Tonelli have found a way to “intercept” pancreatic cancer. By ...
Inside UC Health's new Blood Cancer Healing Center, a dedicated team is committed to clinical trials and research that could ...
Li Ka Shing Foundation and Temasek Trust have committed $12 million to conduct histotripsy trials here. Read more at ...
Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...
Marathon effort aims to give ‘more than hope’ to people with pancreatic cancer - Pancreatic Cancer UK is the TCS London ...
In a recent study, precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS ...
1d
News-Medical.Net on MSNFGFR2 identified as key driver in KRAS-mutated pancreatic cancer progressionPrecancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...
New-onset type 2 diabetes was linked to an increased risk for developing certain cancers typically related to obesity, ...
A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...
Researchers have developed an inexpensive blood test that they say can detect pancreatic cancer — even in its early stages.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results